This podcast episode explores the therapeutic potential of psychedelics in oncology, particularly focusing on how substances like psilocybin and MDMA can help cancer patients manage existential distress and improve quality of life. The discussion covers key topics including:

- The importance of set and setting in psychedelic therapy

- The role of the 5-HT2A receptor in emotional regulation and fear processing

- Clinical trials showing promising results in reducing anxiety and depression in cancer patients

- Ethical considerations, including cultural sensitivity, access to treatment, and patient safety protocols